These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21980344)

  • 1. Robustness analysis and behavior discrimination in enzymatic reaction networks.
    Donzé A; Fanchon E; Gattepaille LM; Maler O; Tracqui P
    PLoS One; 2011; 6(9):e24246. PubMed ID: 21980344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A theoretical model of type I collagen proteolysis by matrix metalloproteinase (MMP) 2 and membrane type 1 MMP in the presence of tissue inhibitor of metalloproteinase 2.
    Karagiannis ED; Popel AS
    J Biol Chem; 2004 Sep; 279(37):39105-14. PubMed ID: 15252025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model.
    Karagiannis ED; Popel AS
    J Theor Biol; 2006 Jan; 238(1):124-45. PubMed ID: 16005020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control and inhibition analysis of complex formation processes.
    Saitou T; Itano K; Hoshino D; Koshikawa N; Seiki M; Ichikawa K; Suzuki T
    Theor Biol Med Model; 2012 Aug; 9():33. PubMed ID: 22863329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase expression and function during fin regeneration in zebrafish: analysis of MT1-MMP, MMP2 and TIMP2.
    Bai S; Thummel R; Godwin AR; Nagase H; Itoh Y; Li L; Evans R; McDermott J; Seiki M; Sarras MP
    Matrix Biol; 2005 Jun; 24(4):247-60. PubMed ID: 15935631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet release of trimolecular complex components MT1-MMP/TIMP2/MMP2: involvement in MMP2 activation and platelet aggregation.
    Kazes I; Elalamy I; Sraer JD; Hatmi M; Nguyen G
    Blood; 2000 Nov; 96(9):3064-9. PubMed ID: 11049985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
    Kandalam V; Basu R; Abraham T; Wang X; Soloway PD; Jaworski DM; Oudit GY; Kassiri Z
    Circ Res; 2010 Mar; 106(4):796-808. PubMed ID: 20056917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIMP independence of matrix metalloproteinase (MMP)-2 activation by membrane type 2 (MT2)-MMP is determined by contributions of both the MT2-MMP catalytic and hemopexin C domains.
    Morrison CJ; Overall CM
    J Biol Chem; 2006 Sep; 281(36):26528-39. PubMed ID: 16825197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is matrix metalloproteinase required in postnatal testicular tubules for germ cell maturation?
    Li R; Zhang JG; Churchill J; Sourial M; Southwell BR; Hutson JM
    J Pediatr Surg; 2012 Sep; 47(9):1724-9. PubMed ID: 22974613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane-type-1 matrix metalloproteinase, matrix metalloproteinase 2, and tissue inhibitor of matrix proteinase 2 in prostate cancer: identification of patients with poor prognosis by immunohistochemistry.
    Trudel D; Fradet Y; Meyer F; Harel F; Têtu B
    Hum Pathol; 2008 May; 39(5):731-9. PubMed ID: 18329693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual Timp deficiencies differentially impact pro-MMP-2 activation.
    English JL; Kassiri Z; Koskivirta I; Atkinson SJ; Di Grappa M; Soloway PD; Nagase H; Vuorio E; Murphy G; Khokha R
    J Biol Chem; 2006 Apr; 281(15):10337-46. PubMed ID: 16469749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-chaperones TIMP2 and AHA1 Competitively Regulate Extracellular HSP90:Client MMP2 Activity and Matrix Proteolysis.
    Baker-Williams AJ; Hashmi F; Budzyński MA; Woodford MR; Gleicher S; Himanen SV; Makedon AM; Friedman D; Cortes S; Namek S; Stetler-Stevenson WG; Bratslavsky G; Bah A; Mollapour M; Sistonen L; Bourboulia D
    Cell Rep; 2019 Aug; 28(7):1894-1906.e6. PubMed ID: 31412254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gelatinase expression and proteolytic activity in giant-cell arteritis.
    Segarra M; García-Martínez A; Sánchez M; Hernández-Rodríguez J; Lozano E; Grau JM; Cid MC
    Ann Rheum Dis; 2007 Nov; 66(11):1429-35. PubMed ID: 17502363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinate action of membrane-type matrix metalloproteinase-1 (MT1-MMP) and MMP-2 enhances pericellular proteolysis and invasion.
    Sato H; Takino T
    Cancer Sci; 2010 Apr; 101(4):843-7. PubMed ID: 20148894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bifurcation discovery tool.
    Chickarmane V; Paladugu SR; Bergmann F; Sauro HM
    Bioinformatics; 2005 Sep; 21(18):3688-90. PubMed ID: 16081475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas.
    Théret N; Musso O; Turlin B; Lotrian D; Bioulac-Sage P; Campion JP; Boudjéma K; Clément B
    Hepatology; 2001 Jul; 34(1):82-8. PubMed ID: 11431737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
    Jo Y; Yeon J; Kim HJ; Lee ST
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo.
    Hofmann UB; Westphal JR; Van Kraats AA; Ruiter DJ; Van Muijen GN
    Int J Cancer; 2000 Jul; 87(1):12-9. PubMed ID: 10861447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis.
    Munshi HG; Wu YI; Mukhopadhyay S; Ottaviano AJ; Sassano A; Koblinski JE; Platanias LC; Stack MS
    J Biol Chem; 2004 Sep; 279(37):39042-50. PubMed ID: 15247230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.